The new study gathered general practitioners’ (GPs) views on providing contraceptive care during the ‘6-week check’ – a routine medical review of mother and baby 6-8 weeks after birth. Conducted by ...

In addition, these Regulatory T cells regulate other injury healing cells to the site, flooding the injury with beneficial ...

If you have any enquiries about our lab please contact us.

Whether you want to research, invest, donate or partner with us to accelerate our life-changing discoveries, we'd be delighted to hear from you. We have opportunities for PhD students, post docs and ...

Behind every treatment that improves human health is a story of discovery. Every day we make new research discoveries and forge partnerships that have a global impact. Read about some of these here.

Dr Luke Formosa is a Group Leader and NHMRC Emerging Leader Fellow at the Monash Biomedical Discovery Institute. He received his PhD in 2016 from La Trobe University, which focussed on understanding ...

Formosa, L. E.*, Maghool, S.*, Sharpe, A. J., Reljic, B., Muellner-Wong, L., Stroud, D. A., Ryan, M. T. & Maher, M. J. (2022) Mitochondrial COA7 is a heme-binding ...

Our group is interested in uncovering how mitochondria work in our cells, how they build their intricate and complex machinery and how they contribute to cellular health. We use this knowledge to ...

Monash University’s Clayton campus came alive with excitement and learning as students were welcomed by Jill and Josh West. A traditional smoking ceremony was led by Josh West amidst the beautiful ...

This new resource will provide evidence-based, accessible information to inform policy and action to reduce the impact of antimicrobial resistance (AMR) on human, animal and environmental health. AMR ...

Innovations in synthetic chemistry have had a profound impact over the past century enabling the discovery and development of life-changing medicines and medical imaging agents. Click chemistry has ...

Building on years of expertise in nucleic acid delivery and nanomedicine design, the COVID-19 pandemic accelerated MIPS scientists' development of mRNA therapeutics using lipid-nanoparticle-based ...